383 related articles for article (PubMed ID: 8661004)
21. [From gene to disease; Krabbe disease and galactosylceramidase deficiency].
Kleijer WJ; van Diggelen OP; Halley DJ; van der Ploeg AT; Mancini GM
Ned Tijdschr Geneeskd; 2004 Apr; 148(17):826-8. PubMed ID: 15141649
[TBL] [Abstract][Full Text] [Related]
22. A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease.
Rafi MA; Luzi P; Chen YQ; Wenger DA
Hum Mol Genet; 1995 Aug; 4(8):1285-9. PubMed ID: 7581365
[TBL] [Abstract][Full Text] [Related]
23. Establishment and characterization of spontaneously immortalized Schwann cells from murine model of globoid cell leukodystrophy (twitcher).
Shen JS; Watabe K; Meng XL; Ida H; Ohashi T; Eto Y
J Neurosci Res; 2002 Jun; 68(5):588-94. PubMed ID: 12111848
[TBL] [Abstract][Full Text] [Related]
24. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
25. Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy.
Lee WC; Tsoi YK; Troendle FJ; DeLucia MW; Ahmed Z; Dicky CA; Dickson DW; Eckman CB
FASEB J; 2007 Aug; 21(10):2520-7. PubMed ID: 17403939
[TBL] [Abstract][Full Text] [Related]
26. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
27. Transgenic rescue of Krabbe disease in the twitcher mouse.
De Gasperi R; Friedrich VL; Perez GM; Senturk E; Wen PH; Kelley K; Elder GA; Gama Sosa MA
Gene Ther; 2004 Aug; 11(15):1188-94. PubMed ID: 15164096
[TBL] [Abstract][Full Text] [Related]
28. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements.
Shen JS; Watabe K; Ohashi T; Eto Y
Gene Ther; 2001 Jul; 8(14):1081-7. PubMed ID: 11526455
[TBL] [Abstract][Full Text] [Related]
29. Cloning and characterization of the canine photoreceptor specific cone-rod homeobox (CRX) gene and evaluation as a candidate for early onset photoreceptor diseases in the dog.
Akhmedov NB; Baldwin VJ; Zangerl B; Kijas JW; Hunter L; Minoofar KD; Mellersh C; Ostrander EA; Acland GM; Farber DB; Aguirre GD
Mol Vis; 2002 Mar; 8():79-84. PubMed ID: 11951083
[TBL] [Abstract][Full Text] [Related]
30. The copper chaperone Atox1 in canine copper toxicosis in Bedlington terriers.
Nanji MS; Cox DW
Genomics; 1999 Nov; 62(1):108-12. PubMed ID: 10585777
[TBL] [Abstract][Full Text] [Related]
31. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
[TBL] [Abstract][Full Text] [Related]
32. Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features.
Rafi MA; Rao HZ; Luzi P; Luddi A; Curtis MT; Wenger DA
Mol Genet Metab; 2015 Mar; 114(3):459-66. PubMed ID: 25533112
[TBL] [Abstract][Full Text] [Related]
33. GALC transduction leads to morphological improvement of the twitcher oligodendrocytes in vivo.
Meng XL; Shen JS; Watabe K; Ohashi T; Eto Y
Mol Genet Metab; 2005 Apr; 84(4):332-43. PubMed ID: 15781194
[TBL] [Abstract][Full Text] [Related]
34. Murine, canine and non-human primate models of Krabbe disease.
Wenger DA
Mol Med Today; 2000 Nov; 6(11):449-51. PubMed ID: 11074371
[TBL] [Abstract][Full Text] [Related]
35. Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients.
Furuya H; Kukita Y; Nagano S; Sakai Y; Yamashita Y; Fukuyama H; Inatomi Y; Saito Y; Koike R; Tsuji S; Fukumaki Y; Hayashi K; Kobayashi T
Hum Genet; 1997 Sep; 100(3-4):450-6. PubMed ID: 9272171
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment.
Sakai N
Brain Dev; 2009 Aug; 31(7):485-7. PubMed ID: 19332366
[TBL] [Abstract][Full Text] [Related]
37. Structure and organization of the human galactocerebrosidase (GALC) gene.
Luzi P; Rafi MA; Wenger DA
Genomics; 1995 Mar; 26(2):407-9. PubMed ID: 7601472
[TBL] [Abstract][Full Text] [Related]
38. Molecular defects in Krabbe disease.
Tatsumi N; Inui K; Sakai N; Fukushima H; Nishimoto J; Yanagihara I; Nishigaki T; Tsukamoto H; Fu L; Taniike M
Hum Mol Genet; 1995 Oct; 4(10):1865-8. PubMed ID: 8595408
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe's disease.
Sakai N; Inui K; Tatsumi N; Fukushima H; Nishigaki T; Taniike M; Nishimoto J; Tsukamoto H; Yanagihara I; Ozono K; Okada S
J Neurochem; 1996 Mar; 66(3):1118-24. PubMed ID: 8769874
[TBL] [Abstract][Full Text] [Related]
40. A single mutation in the GALC gene is responsible for the majority of late onset Krabbe disease patients in the Catania (Sicily, Italy) region.
Lissens W; Arena A; Seneca S; Rafi M; Sorge G; Liebaers I; Wenger D; Fiumara A
Hum Mutat; 2007 Jul; 28(7):742. PubMed ID: 17579360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
